Prelude Therapeutics IncorporatedPRLDNASDAQ
Loading
EPS Over TimeExpanding
Percentile Rank71
Studio
Year-over-Year Change

Earnings per share

Latest
-1.35
↑ 49% vs avg
Percentile
P71
Within normal range
Streak
4 yr
Consecutive growthExpanding
Average
-2.64
Historical baseline
PeriodValueYoY Change
TTM-1.35+19.6%
2024-1.68+16.8%
2023-2.02+11.0%
2022-2.27+2.6%
2021-2.33-79.2%
2020-1.30-52.9%
2019-0.85+90.9%
2018-9.31-